It goes both ways, there’s little support as most of the register is LT and holding strong. LT holders are spent & waiting on a strategic update. It’s sold off on low volume. Fast down, faster up.
The thing your missing here, along with IXC, and the many other tickers you have commented on that are in the toilet, is your not appreciating the fundamentals enough.
My view is looking over a medium term, Biotech FA should be considered #1, TA #2 when looking at the trend for an entry.
If you’re trading, on a short time frame, TA #1 no problem. FA #2 to understand there’s no surprises about to cause a 50% decline, as you just experienced. (All thought you likely had stop losses on the way to the bottom.
You can always make a chart fit your narrative, so offering your advice will benefit different people on different time horizons.
Play your indicators & act on them. But trying to be “right” on declines & offering nothing in positive on the way up, highlights your motive.
- Forums
- ASX - By Stock
- RAC - Charts & Price Action
It goes both ways, there’s little support as most of the...
-
- There are more pages in this discussion • 6,565 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.47 |
Change
-0.005(0.34%) |
Mkt cap ! $249.7M |
Open | High | Low | Value | Volume |
$1.48 | $1.50 | $1.46 | $129.2K | 87.73K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 7418 | $1.47 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.49 | 38353 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 7418 | 1.465 |
1 | 11000 | 1.460 |
1 | 13000 | 1.455 |
4 | 47100 | 1.450 |
2 | 25548 | 1.440 |
Price($) | Vol. | No. |
---|---|---|
1.490 | 38353 | 1 |
1.525 | 1000 | 1 |
1.535 | 2285 | 1 |
1.575 | 2000 | 1 |
1.580 | 12717 | 2 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online